News release and current reports

Up-to-date information for investors and shareholders can be found within the news release section issued in accordance with:

  • Law no. 24/2017 on issuers of financial instruments and market operations,
  • The Regulation of the Financial Supervisory Authority no. 5/2018 on Issuers and Market Operations
  • Law no. 111/2016 for the approval of GEO109/2011 on the corporate governance of public enterprises,
  • Law no. 31/1990 republished, with all subsequent amendments,
  • Articles of Association.

News release and current reports archive

Select report

Select release

Notice of availability Q1 2026 Report
2026-05-27

BROWSE PDF

Antibiotice SA is accelerating its strategic investments
2026-05-21

BROWSE PDF

Antibiotice SA will receive counseling from the EIB
2026-05-13

BROWSE PDF

Notice of availability – The report on the key performance indicators for the first quarter of 2026
2026-04-21

BROWSE PDF

Availability for the Annual Report 2025
2026-03-27

BROWSE PDF

Critical medicines and biosimilars – the top priority of new investment projects at Antibiotice S.A.
2026-03-03

BROWSE PDF

Availability for the Annual Report 2025 – PRELIMINARY RESULTS
2026-02-26

BROWSE PDF

Notice of availability – The report on the key performance indicators for the fourth quarter of 2025
2026-01-22

BROWSE PDF